April 8, 2019 / 7:46 PM / 15 days ago

U.S. FDA approves GSK's two-drug HIV treatment

April 8 (Reuters) - The U.S. Food and Drug Administration said on Monday it had approved GlaxoSmithKline Plc’s two-drug HIV treatment.

The approval was granted to GSK’s majority-owned HIV unit ViiV Healthcare, the FDA said. (Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below